ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/01/2026
Back to search
Official data from USPTO
ONCODETECT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ONCODETECT
ST13
US500000097915548Class
10, 42, 44
Filing
97915548
Registration
7969494
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
06/02/2026
Trademark type
Word
Nice classes
10, 42, 44
Filing date
05/01/2023
Registration date
09/30/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/30/2025
Last transaction
06/02/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/28/2025
First use in commerce
03/28/2025
Drawing code
4
Owner type
03
Owner location
Madison, WI, US
Examiner
FARRAG, SHERIF G
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Genomic Health, Inc.
Genomic Health, Inc.
Representatives
Sana Hakim K&L GATES LLP
Technical classification
Nice Classes
Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Blood collection kit comprised of blood collecting tubes for use in the detection of tumor-specific biomarkers in tumor tissue and blood testing for the recurrence of cancer and the ongoing monitoring of therapeutic effectiveness
Class 42
Providing laboratory research services in the field of genetic testing for the detection and screening of cancerdevelopment of assays for detection of tumor-specific biomarkers in tumor tissue and blood; medical and scientific laboratory services in the field of genetic testing for the detection and screening of cancerdevelopment of assays for detection of tumor-specific biomarkers in tumor tissue and blood
Class 44
Medical testing servicesgenetic testing for the detection and screening of canceruse of a bespoke assay for detection of tumor-specific biomarkers in tumor tissue and bloodtesting for the recurrence of cancer and the ongoing monitoring of therapeutic effectiveness; providing medical testing services for the detection and screening of cancer and information for treatment purposes in the field of genetic research and disease classificationuse of a bespoke assay for detection of tumor-specific biomarkers in tumor tissue and bloodtesting for the recurrence of cancer and the ongoing monitoring of therapeutic effectiveness
Publications
History of USPTO decisions and trademark events.
38 publications found
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
01/23/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/30/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
09/30/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/08/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/08/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/20/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/09/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/09/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/09/2025
IUAF
USE AMENDMENT FILED
05/29/2025
EISU
TEAS STATEMENT OF USE RECEIVED
05/29/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/25/2025
EX1G
SOU EXTENSION 1 GRANTED
02/25/2025
EXT1
SOU EXTENSION 1 FILED
02/24/2025
EEXT
SOU TEAS EXTENSION RECEIVED
02/24/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/03/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/09/2024
PUBO
PUBLISHED FOR OPPOSITION
07/09/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/19/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/05/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/22/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/22/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/22/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
03/04/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
03/04/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/04/2023
GNRT
NON-FINAL ACTION E-MAILED
12/04/2023
CNRT
NON-FINAL ACTION WRITTEN
12/04/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/02/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/02/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/02/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/11/2023
GNRT
NON-FINAL ACTION E-MAILED
08/11/2023
CNRT
NON-FINAL ACTION WRITTEN
08/11/2023
DOCK
ASSIGNED TO EXAMINER
08/08/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/30/2023
NWAP
NEW APPLICATION ENTERED
05/04/2023
Continuous trademark protection
Get notified about every new filing that threatens ONCODETECT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.